Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive)

Explore clinical trials studying Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive) trial results

Recruiting

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

NCT01403402

Conditions: Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations), Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy), Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan), +89 more
Locations: Congenital Muscle Disease International Registry (www.cmdir.org) Lakewood, California, United States

View Trial Details

Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive)

Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive) trial results

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Related conditions